Genentech reviews

3.9

74% would recommend to a friend

(552 total reviews)
avatar

Ashley Magargee

83% approve of CEO

55% positive business outlook

Reviews by job title

552 reviews

Reviews about "Compensation"

Return to all reviews
4.0
Jul 24, 2024
Recommend
CEO approval
Business Outlook

Pros

-clinical research that puts patients first -strong infrastructure -learning opportunities -good benefits -emphasis on D&I in all facets of business -on campus gym and access to bay trail

Cons

-no/low amount of promotions for non science role -new leadership is changing the culture and don’t seem open to any ideas from the long time employees that made Genentech great and had no power over leader decisions or failed molecules -return to office is more strict than pre-COVID -huge budget constraints that limit our ability to engage with sites or attend development conferences for operations staff -departments has vastly different and unequal “perks” including seemingly unlimited travel for some groups and little to none for others -staff is over worked with high performers taking a much larger share of workload without being compensated via yearly performance bonus -there’s been quite a bit of attrition without rehiring -morale is low -no stock purchase options and stock awarded with compensation package has been under performing for years

4.0
Jul 18, 2024
Recommend
CEO approval
Business Outlook

Pros

Good benefits and interesting work

Cons

Started with the promise of flexible work and are slowly encroaching on it. Now a minimum of 3 days on site is required, regardless of your role/job requirements. Pay is surprisingly lower and less competitive than comparable positions elsewhere, despite benefits.

Viewing 85 - 87 of 552 Reviews

Glassdoor has 5,071 Genentech reviews submitted anonymously by Genentech employees. Read employee reviews and ratings on Glassdoor to decide if Genentech is right for you.